[Abstract] [Full Text PDF] (in Japanese / 1704KB) [Members Only And Two Factor Auth.]

J.Jpn. Surg. Soc.. 84(9): 778-781, 1983


Report on the annual meeting

SURGICAL TREATMENT FOR METASTATIC LUNG TUMORS

Department of Thoracic Surgery, Chest Disease Research Institute, Kyoto University, Kyoto, Japan

Motohiko Ito, Akio Mitsuoka, Toshihiko Taki, Koichi Tamura, Hirofumi Kato, Yoshihiko Shimizu, Takashi Teramatsu

Surgical treatments were performed in 88 cases of metastatic lung tumors, where 5 years survival rate in all resected cases was 37.5%. We report our principles on the surgical treatment for metastatic lung tumors.
First of all, the bioligical characteristics of the primary lesion is among the most important factors in considering the indication for the surgical teratment in metastatic lung tumors. For example, chemotherapy must be the first choice in treating lung metastasis of choriocarcinoma, and hormone therapy in lung metastasis of mammary carcinoma. On the other hand, such tumors as osteogenic sarcoma, soft tissue sarcoma, colorectal carcinoma and Grawitz’s tumor, should be treated by surgery.
Another point in the surgery of the metastatic lung tumor is the choice of the mode of operation for the solitary metastatic tumor according to tumor type. As a principle, partial or segmental resection is preferably chosen for metastatic lung tumor. However, the location of the lung tumor, tumor size, hilar lymph node metastasis and the pattern of invasion to the surrounding lung tissue must be considered to decide the surgical procedure. From these considerations, the segmental or partial resection for metastatic sarcomas and the lobectomy for the metastatic carcinomas are appropriate in general.


<< To previous pageTo next page >>

To read the PDF file you will need Adobe Reader installed on your computer.